Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation routing
Prioritisation routing
None selected (376)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (295)
Apply filters
Showing 31 to 40 of 376
Sort by
Decision date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Topic prioritisation
Title
Prioritisation routing
Decision
Decision date
Bioinductive collagen scaffold (Regeneten) for rotator cuf repair
None selected
Not selected
26 June 2025
Orbital atherectomy for calcified coronary artery disease
None selected
Not selected
26 June 2025
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]
None selected
Not selected
16 June 2025
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]
None selected
Not selected
16 June 2025
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]
None selected
Not selected
16 June 2025
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]
None selected
Not selected
16 June 2025
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]
None selected
Not selected
16 June 2025
Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165]
None selected
Not selected
16 June 2025
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]
None selected
Not selected
16 June 2025
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]
None selected
Not selected
16 June 2025
Previous page
1
2
3
Current page
4
5
6
…
38
Page
4
of
38
Next page
Results per page
10
25
50
All
Back to top